BIOTECHNOLOGY INNOVATION ORGANIZATION
DC · US
Tracked direct giving
$0
Tracked donations to candidate
$0
LDA reported lobbying spend
$11,130,000
Connections
9
Dark Money Spending
Election spending by organizations that do not disclose their donors. Dark money flows through 501(c)(4) social welfare organizations, 501(c)(6) trade associations, and similar entities that are not required to reveal their funders. Figures below are never combined with disclosed-donor totals.
IRS 990 Schedule I Grant Chain
Grants between nonprofits reported on IRS Form 990 Schedule I. These inter-organizational transfers are a key pathway in dark money flows — a nonprofit may receive a grant from one entity and then spend that money on election ads.
IRS 990 Schedule I grants received
$73,700
| Grantor | Amount | Tax Year | Purpose |
|---|---|---|---|
| ALZHEIMERS DRUG DISCOVERY FOUNDATION | $73,700 | 2023 | ALZHEIMERS RESEARCH |
Source: IRS Form 990 Schedule I (Grants and Other Assistance to Organizations) via ProPublica Nonprofit Explorer and IRS 990 XML e-files. Grant amounts represent the most recent filing year available.
IRS 990 data lags a year or more behind filing. Grants shown are for the stated tax year and do not establish current-cycle funding.
Methodology Disclosure
Dark money figures are derived from FEC Form 5 (independent expenditures by non-committee organizations) and Form 9 (electioneering communications). These filings capture spending on ads and election communications but do not reveal the identity of the organization's donors. QPQ totals may differ from benchmarks like the Brennan Center's estimates because QPQ includes all Form 5 filers, while some benchmarks count only a subset of non-disclosing nonprofits. Grant chain data is from IRS Form 990 Schedule I and may not include all years or all grantee organizations.
Lobbying Activity Detail
Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.
Top Lobbying Issues
Lobbying Firms Retained
Bills Referenced in Lobbying Filings
Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.
Click a node to see details
Double-click to expand its connections
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| Employed by | AKIN GUMP STRAUSS HAUER & FELD | Hired AKIN GUMP STRAUSS HAUER & FELD to lobby on Pharmaceuticals | Source |
| Lobbied for | Pharmacy Benefit Manager Reform Act | LDA filing: lobbied on PBM Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $60,000 | Source |
| Lobbied for | MARCH-IN Rights Proposal (NIH Framework) | LDA filing: lobbied on NIH March-In Rights, period 1st Quarter (Jan 1 - Mar 31), reported amount $2,430,000 | Source |
| Lobbied for | 2023 Farm Bill Reauthorization (Corn Provisions) | LDA filing: lobbied on Farm Bill Corn Provisions, period 1st Quarter (Jan 1 - Mar 31), reported amount $2,430,000 | Source |
| commented_on | Federal Trade Commission | Public comment on FTC-2023-0040: Premerger Notification; Reporting and Waiting Period Requirements | Source |
| commented_on | Centers for Medicare & Medicaid Services | Public comment on CMS-2025-1889: Global Benchmark for Efficient Drug Pricing Model | Source |
| Lobbied for | Rights to Federally Funded Inventions and Licensing of Government Owned Inventions | Lobbied on march-in — matched LDA filing topic to Federal Register rule. | Source |
| Lobbied for | Action to Delay Effective Date Consistent With Congressionally Enacted Moratorium | Lobbied on pbm — matched LDA filing topic to Federal Register rule. | Source |
| Received money from | ALZHEIMERS DRUG DISCOVERY FOUNDATION | IRS 990 Schedule I grant of $73,700 (tax year 2023). Purpose: ALZHEIMERS RESEARCH | Source |